| Literature DB >> 24188825 |
Ingo Rekittke1, Elena Olkhova, Jochen Wiesner, Ulrike Demmer, Eberhard Warkentin, Hassan Jomaa, Ulrich Ermler.
Abstract
Terpenoid precursor biosynthesis occurs in human and many pathogenic organisms via the mevalonate and 2-C-methyl-d-erythritol-4-phosphate (MEP) pathways, respectively. We determined the X-ray structure of the Fe/S containing (E)-4-hydroxy-3-methyl-but-2-enyl-diphosphate reductase (LytB) of the pathogenic protozoa Plasmodium falciparum which catalyzes the terminal step of the MEP pathway. The cloverleaf fold and the active site of P. falciparum LytB corresponds to those of the Aquifex aeolicus and Escherichia coli enzymes. Its distinct electron donor [2Fe-2S] ferredoxin was modeled to its binding site by docking calculations. The presented structural data provide a platform for a rational search of anti-malarian drugs.Entities:
Keywords: (E)-4-hydroxy-3-methyl-but-2-enyl-diphosphate; (E)-4-hydroxy-3-methyl-but-2-enyl-diphosphate reductase; 2-C-methyl-d-erythritol-2,4-cyclo-diphosphate; 2-C-methyl-d-erythritol-4-phosphate; DMAPP; Drug design; HMBPP; IPP; Isoprenoid biosynthesis; LytB; MEP; MEcPP; Plasmodium falciparum; X-ray structure; dimethylallyl diphosphate; isopentenyl diphosphate
Mesh：
Substances：
Year: 2013 PMID： 24188825 DOI： 10.1016/j.febslet.2013.10.029
Source DB: PubMed Journal: FEBS Lett ISSN： 0014-5793 Impact factor: 4.124